• Activity INFORMATION

  Overview

  We live in an “Opioid Crisis” where someone dies approximately every 7 minutes from drug overdose. So just how do we end this “Opioid Crisis,” or, at least, how do we as healthcare professionals contribute to the progress of society in the right direction? In this monograph, we will review overall pain management etiology; numerous non-pharmacological and pharmacological treatment options (with particular attention on opioid medications), opioid overdose reversal treatments; along with not only how to identify drug-seeking and diversion behaviors, but possible actions to take when the behaviors are suspected. The West Virginia Controlled Substances Monitoring Program (CSMP) will, of course, also be discussed for its expected impact on adherence and diversion. We will also review West Virginia-specific controlled substance laws and trends, such as controlled substance classifications, prescribing authorities, the Opioid Reduction Act of 2018, the naloxone standing order, and DEA Red Flags. Unlike opioids, this monograph is intended to open one’s eyes, elevate blood pressure and/or heart rate, and increase cognition (in relation to the Opioid Crisis).
  
  
  This program has been APPROVED for WV Pharmacists to fulfill the requirement of Drug Diversion.  2019-06-01-DDT
  

  Handouts

  • Homestudy PDF :   19068H03(001).pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recognize the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.

  Recognize the etiology and epidemiology of chronic pain.

  Recognize the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.

  Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.

  Identify when and how to initiate, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines.

  Describe West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.

  Identify how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code§ 60A-9-l.

  Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.

  Identify how to be compliant with federal and state-controlled substances laws.

  Nurse

  Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.

  Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.

  Recognize the etiology and epidemiology of chronic pain.

  Recognize the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.

  Describe West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.

  Identify when and how to initiate, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines.

  Identify how to be compliant with federal and state-controlled substances laws.

  Recognize the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.

  Identify how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code§ 60A-9-l.

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-720696

  Universal Activity Number

  Pharmacist 0798-0000-19-068-H03-P
  Nurse 0798-0000-19-068-H03-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mark  Garofoli, PharmD, MBA, BCGP, CPE, CTTS Assistant Professor, West Virginia University School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).